🇺🇸 FDA
Pipeline program

CETUXIMAB

Phase 3 small_molecule active

Quick answer

CETUXIMAB for oral squamous cell carcinoma is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
oral squamous cell carcinoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials